2-(1-Propen-1-yl)thiolane | 73543-16-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 硫杂环戊烷
• 英文名称: 2-(1-Propen-1-yl)thiolane
• 英文别名: 2-[(E)-prop-1-enyl]thiolane
• CAS: 73543-16-5
• 化学式: C₇H₁₂S
• 分子量: 128.238
• InChiKey: WWPFJERTOAFQFO-DUXPYHPUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  8
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  25.3
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  3-Bromopropyl crotyl sulfide 在 lithium diisopropyl amide 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 生成 2-(1-Propen-1-yl)thiolane 、 2-(1-Propen-1-yl)thiolane
  参考文献：
  名称：

  Stereospecific transannular cyclization of (Z)- and (E)-thiacyclooct-4-enes: synthesis and carbon-13 nuclear magnetic resonance spectra of substituted cis-1-thioniabicyclo[3.3.0]octane salts. Conformational analysis (force field) of (E)-thiacyclooct-4-ene and its 2- and 3-methyl derivatives

  摘要：

  DOI：

  10.1021/jo01301a020

文献信息

• NOVEL LUPANE DERIVATIVES
  申请人：Moinet Christophe

  公开号：US20110077227A1

  公开（公告）日：2011-03-31

  The invention relates to 21-keto triterpene compounds of formula (I): wherein R 1 , X, and Y are as defined herein, and pharmaceutically acceptable salts and solvates thereof. These compounds exhibit significant anti-HIV activity. Thus, the invention also relates to methods for prevention or treatment of HIV infections by administering therapeutically effective amounts of a compound of formula (I), or a pharmaceutically acceptable salt or solvate thereof to a subject in need of such treatment.

  该发明涉及式(I)的21-酮三萜化合物：其中R1、X和Y如本文所定义，并且其药学上可接受的盐和溶剂化合物。这些化合物表现出显著的抗HIV活性。因此，该发明还涉及通过向需要此类治疗的受试者施用式(I)的化合物、或其药学上可接受的盐或溶剂化合合物的治疗有效量来预防或治疗HIV感染的方法。
• NOVEL C-21-KETO LUPANE DERIVATIVES PREPARATION AND USE THEREOF
  申请人：Moinet Christophe

  公开号：US20110077228A1

  公开（公告）日：2011-03-31

  The invention relates to 21-keto triterpene compounds of formula (I): wherein R 1 , X and Y are as defined herein, and pharmaceutically acceptable salts and solvates thereof. These compounds exhibit significant anti-HIV activity. Thus, the invention also relates to methods for prevention or treatment of HIV infections by administering therapeutically effective amounts of a compound of formula (I), or a pharmaceutically acceptable salt or solvate thereof to a subject in need of such treatment.

  该发明涉及式(I)的21-酮三萜化合物：其中R1、X和Y如本文所定义，并且其药用可接受的盐和溶剂化合物。这些化合物表现出显著的抗HIV活性。因此，该发明还涉及通过向需要此类治疗的受试者施用式(I)的化合物或其药用可接受的盐或溶剂，来预防或治疗HIV感染的方法。
• BENZIMIDAZOLE ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
  申请人：Henderson James A.

  公开号：US20110172238A1

  公开（公告）日：2011-07-14

  Compounds represented by formula I: or pharmaceutically acceptable salts and solvates thereof, wherein A, B, B′, X, Y, R 1 , R 1 ′, R 2 , R 2 ′, R 3 , R 3 ′, R 5 , R 5 ′, R 6 , m, n, or p are as defined herein, are useful for treating flaviviridae viral infections.

  公式I所代表的化合物，或其药学上可接受的盐和溶剂化物，其中A、B、B'、X、Y、R1、R1'、R2、R2'、R3、R3'、R5、R5'、R6、m、n或p的定义如本文所述，可用于治疗黄病毒科病毒感染。
• NOVEL 17 BETA LUPANE DERIVATIVES
  申请人：Moinet Christophe

  公开号：US20110077251A1

  公开（公告）日：2011-03-31

  The invention relates to 17β lupane derivatives of formula (I): wherein R 1 and X are as defined herein, and pharmaceutically acceptable salts and solvates thereof. These compounds exhibit significant anti-HIV activity. Thus, the invention also relates to methods for prevention or treatment of HIV infection by administering therapeutically effective amounts of a compound of formula (I), or a pharmaceutically acceptable salt or solvate thereof to a subject in need of such treatment.
• US7569600B2
  申请人：——

  公开号：US7569600B2

  公开（公告）日：2009-08-04

表征谱图